The Food and Drug Administration (FDA) announced a further 60-day delay in the implementation of the final rule on “Nonprescription Drug Product With an Additional Condition for Nonprescription Use” (ACNU). Originally published on December 26, 2024, with an effective date of January 27, 2025 (Impact Health summary), the rule was first postponed to March 21, 2025, following a Regulatory Freeze… (Colocho, March 21, 2025) #Food and Drug Administration